Investor Relations

Harris & Harris Group, Inc.® is an internally managed investment company. We have elected to be regulated as a business development company ("BDC") under the Investment Company Act of 1940, (the "1940 Act"). For tax purposes, we have elected to be treated as a regulated investment company ("RIC") under Subchapter M of the Internal Revenue Code of 1986 (the "Code"). We were incorporated under the laws of the state of New York in August 1981. We are overseen by our Board of Directors and managed by our officers and have no external investment advisor.
 
Harris & Harris Group builds transformative companies enabled by disruptive science by identifying and investing in such companies and then providing strategic, operational and management resources, and creative financial solutions.

View all »   RSSRecent Releases

06/23/16
TARA Biosystems Appoints Robert Langer, Ph.D., to Board of Directors

06/22/16
Harris & Harris Group Reminds Interested Accredited Investors of the Limited Time Remaining to Subscribe to Its D-Wave Systems-Focused Co-Investment Fund Offering Available at www.banq.co

06/17/16
Mersana Therapeutics Announces Series C Financing

06/09/16
Harris & Harris Group Announces the Availability of a Presentation by the CEO of D-Wave Systems and Reminds Interested Accredited Investors of the Limited-Time Opportunity to Invest in H&H Co-Investment Partners, LLC D-Wave Series J Available at www.banq.co

NASDAQTINY
Price:$1.78
Change+0.57% 0.01
Day High$1.78
Day Low$1.72
Volume42,567

As of 3:59 PM ET on 06/24/16
Quote delayed at least 20 minutes.

More

Corporate Headquarters
1450 Broadway, 24th Floor
New York, NY 10018
Phone: 212 582 0900
Fax: 212 582 9563
admin@hhvc.com

West Coast Office:
530 Lytton Avenue - 2nd Floor
Palo Alto, CA 94301
Phone: 650 617 3386
Fax: 650 617 3201